These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 24561758)

  • 1. Effect of β-blockers on cardiac and pulmonary events and death in older adults with cardiovascular disease and chronic obstructive pulmonary disease.
    Lee DS; Markwardt S; McAvay GJ; Gross CP; Goeres LM; Han L; Peduzzi P; Lin H; Dodson JA; Tinetti ME
    Med Care; 2014 Mar; 52 Suppl 3(0 3):S45-51. PubMed ID: 24561758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of β blockers on mortality after myocardial infarction in adults with COPD: population based cohort study of UK electronic healthcare records.
    Quint JK; Herrett E; Bhaskaran K; Timmis A; Hemingway H; Wedzicha JA; Smeeth L
    BMJ; 2013 Nov; 347():f6650. PubMed ID: 24270505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-Blocker Use and Clinical Outcomes in Patients With COPD Following Acute Myocardial Infarction.
    LaFon DC; Helgeson ES; Lindberg S; Voelker H; Bhatt SP; Casaburi R; Cassady SJ; Connett J; Criner GJ; Hatipoglu U; Kaminsky DA; Kunisaki KM; Lazarus SC; McEvoy CE; Reed RM; Sciurba FC; Stringer W; Dransfield MT
    JAMA Netw Open; 2024 May; 7(5):e247535. PubMed ID: 38771577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of beta blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study.
    Short PM; Lipworth SI; Elder DH; Schembri S; Lipworth BJ
    BMJ; 2011 May; 342():d2549. PubMed ID: 21558357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of beta-blocker treatment with mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left ventricular dysfunction: a propensity matched-cohort analysis from the High-Risk Myocardial Infarction Database Initiative.
    Coiro S; Girerd N; Rossignol P; Ferreira JP; Maggioni A; Pitt B; Tritto I; Ambrosio G; Dickstein K; Zannad F
    Eur J Heart Fail; 2017 Feb; 19(2):271-279. PubMed ID: 27774703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving outcomes in chronic obstructive pulmonary disease by taking beta-blockers after acute myocardial infarction: a nationwide observational study.
    Wang WH; Cheng CC; Mar GY; Wei KC; Huang WC; Liu CP
    Heart Vessels; 2019 Jul; 34(7):1158-1167. PubMed ID: 30680495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
    Hawkins NM; Huang Z; Pieper KS; Solomon SD; Kober L; Velazquez EJ; Swedberg K; Pfeffer MA; McMurray JJ; Maggioni AP;
    Eur J Heart Fail; 2009 Mar; 11(3):292-8. PubMed ID: 19176539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-blockers after acute myocardial infarction in patients with chronic obstructive pulmonary disease: A nationwide population-based observational study.
    Su TH; Chang SH; Kuo CF; Liu PH; Chan YL
    PLoS One; 2019; 14(3):e0213187. PubMed ID: 30835781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-blockers for suspected or diagnosed acute myocardial infarction.
    Safi S; Sethi NJ; Nielsen EE; Feinberg J; Jakobsen JC; Gluud C
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD012484. PubMed ID: 31845756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Beta blockers reduce mortality after myocardial infarct - also in COPD patients].
    Markun S
    Praxis (Bern 1994); 2014 Apr; 103(8):471-2. PubMed ID: 24713385
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of Comorbidities and Commonly Used Drugs on Mortality in COPD - Real-World Data from a Primary Care Setting.
    Ellingsen J; Johansson G; Larsson K; Lisspers K; Malinovschi A; Ställberg B; Thuresson M; Janson C
    Int J Chron Obstruct Pulmon Dis; 2020; 15():235-245. PubMed ID: 32099348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rates of hospitalizations and emergency department visits in patients with asthma and chronic obstructive pulmonary disease taking beta-blockers.
    Brooks TW; Creekmore FM; Young DC; Asche CV; Oberg B; Samuelson WM
    Pharmacotherapy; 2007 May; 27(5):684-90. PubMed ID: 17461703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-acting antimuscarinic therapy in patients with chronic obstructive pulmonary disease receiving beta-blockers.
    Chapman KR; Wise RA; Scirica BM; Bhatt DL; Daoud SZ; Lythgoe D; Gil EG
    Respir Res; 2021 Oct; 22(1):272. PubMed ID: 34686204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of β-Blockers With Functional Outcomes, Death, and Rehospitalization in Older Nursing Home Residents After Acute Myocardial Infarction.
    Steinman MA; Zullo AR; Lee Y; Daiello LA; Boscardin WJ; Dore DD; Gan S; Fung K; Lee SJ; Komaiko KD; Mor V
    JAMA Intern Med; 2017 Feb; 177(2):254-262. PubMed ID: 27942713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease.
    Rutten FH; Zuithoff NP; Hak E; Grobbee DE; Hoes AW
    Arch Intern Med; 2010 May; 170(10):880-7. PubMed ID: 20498416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of cardioselective β-blockers and overall death and cardiovascular outcomes in patients with COPD: a population-based cohort study.
    Dong YH; Chang CH; Wu LC; Lai MS
    Eur J Clin Pharmacol; 2016 Oct; 72(10):1265-1273. PubMed ID: 27444174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-blocker use and mortality in COPD patients after myocardial infarction: a Swedish nationwide observational study.
    Andell P; Erlinge D; Smith JG; Sundström J; Lindahl B; James S; Koul S
    J Am Heart Assoc; 2015 Apr; 4(4):. PubMed ID: 25854796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project.
    Krumholz HM; Radford MJ; Wang Y; Chen J; Heiat A; Marciniak TA
    JAMA; 1998 Aug; 280(7):623-9. PubMed ID: 9718054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-hypertensive medications and cardiovascular events in older adults with multiple chronic conditions.
    Tinetti ME; Han L; McAvay GJ; Lee DS; Peduzzi P; Dodson JA; Gross CP; Zhou B; Lin H
    PLoS One; 2014; 9(3):e90733. PubMed ID: 24614535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of potential bias in a comparison of β blockers and calcium channel blockers in patients with chronic obstructive pulmonary disease and acute coronary syndrome: results of a multinational study.
    Dong YH; Alcusky M; Maio V; Liu J; Liu M; Wu LC; Chang CH; Lai MS; Gagne JJ
    BMJ Open; 2017 Mar; 7(3):e012997. PubMed ID: 28363921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.